NCT00117299: PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib |
|
|
| Completed | 2 | 45 | Europe | PTK787/ZK222584, vatalanib | University of Helsinki, Bayer | Sarcoma | 09/07 | 01/09 | | |
NCT00348790: Vatalanib in Treating Patients With Recurrent or Progressive Meningioma |
|
|
| Completed | 2 | 25 | US | vatalanib, PTK787, ZK 222584 | Northwestern University, Novartis | Brain and Central Nervous System Tumors, Sarcoma | 11/10 | 07/13 | | |
2004-001605-10: A Phase II, open-label study of PTK787/ZK222584 in the treatment of metastatic gastrointestinal stromal tumors GISTs resistant to imatinib mesylate |
|
|
| Ongoing | 2 | 10 | Europe | L01XX, PTK787/ZK222584, | ISTITUTO NAZIONALE PER LA CURA TUMORI | Metastatic gastrointestinal stromal tumors GISTs | | | | |
